Nascent Pharmaceuticals, Inc. Company Profile

21:22 EDT 18th March 2018 | BioPortfolio

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm. Since 1992 Advantage has raised more than $700 million in institutional capital and has invested in a wide variety of companies and real estate projects. The firm targets its investment activities in geographic areas that are underserved by venture capital.


533 Airport Boulevard, Suite 400
United States of America


Phone: 919-806-4569

News Articles [505 Associated News Articles listed on BioPortfolio]

Global delay in nascent strand DNA methylation

Proteomics: Nascent proteome labeling in vivo

The (still somewhat mysterious) science behind the microbiome

Though nascent, microbiome research is offering valuable insights about how tiny organisms improve — and threaten — human health.

Building A Biosimilars Market: Lessons From The US Launches

Provider trust in the biosimilar is as important as price in the nascent market and biosimilars need more commercialization support...   

Scaling A Startup In A New Industry

The genomics industry is booming, but what were the challenges of growing a startup at a time when the industry itself was only at a nascent stage? This article explores what lessons can be learned f...

Security Robots Market: Rising Use by Military and Defense Sector to Fuel Demand - Transparency ...

The  global security robots market is still at a nascent stage. Given the scenario, it witnessed only a handful of companies emerging as established players Read more...

FDA Warns against ‘Do It Yourself’ Gene Therapy Kits

(Boston Business Journal) – The U.S. Food and Drug Administration has issued a stern warning against the use of “do it yourself” gene therapy kits, pushing back against a nascent “biohacke...

Salix Pharmaceuticals (SLXP) vs. Its Rivals Head to Head Survey

Salix Pharmaceuticals is one of 19 public companies in the "Specialty & Advanced Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Salix Pharmaceuticals to related...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [186 Associated PubMed Articles listed on BioPortfolio]

Measuring Nascent Transcripts by Nascent-seq.

A complete understanding of transcription and co-transcriptional RNA processing events by polymerase requires precise and robust approaches to visualize polymerase progress and quantify nascent transc...

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Intrinsic Ribosome Destabilization Underlies Translation and Provides an Organism with a Strategy of Environmental Sensing.

Nascent polypeptides can modulate the polypeptide elongation speed on the ribosome. Here, we show that nascent chains can even destabilize the translating Escherichia coli ribosome from within. This p...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Clinical Trials [212 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1311 Associated Companies listed on BioPortfolio]

Nascent Pharmaceuticals, Inc.

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm....

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

Atlantic Technology Ventures Incorproated

Atlantic Technology Ventures, Inc. (OTC: ATLC.OB), formerly known as Atlantic Pharmaceuticals, Inc., is a technology incubator engaged in developing and commercializing a diverse portfolio of patented...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Nascent Biotech Inc.

NBI is a biotechnology company developing human Monoclonal Antibodies (mAb’s) for immunotherapy of cancer. Its lead therapeutic candidate, Pritumumab, was the first human ant...

More Information about "Nascent Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Nascent Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Nascent Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Nascent Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nascent Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Nascent Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record